Topic: whole-genome sequencing
Caris Life Sciences has launched a new whole transcriptome sequencing test for tumor RNA analysis.
Using a new genetic map, deCODE scientists found a tight link between genetic recombination and mutations—insight that could boost medical research.
IQVIA and Genomics England plan to link clinical results with deidentified genomics data to generate evidence for personalized medicine.
A proof-of-concept study suggests that combines AI and the whole-genome sequencing of tumors could scale precision medicine for cancer.
For the first time, Stanford University researchers have used a new type of whole-genome sequencing to diagnose a patient.
Singapore’s state-owned investment firm Temasek and Chinese internet tycoon Jack Ma-backed Yunfeng Capital have led a $75 million Series B into WuXi NextCODE.